Dr. Joseph Pinzone is Chief Medical Officer of Hyperthermia Cancer Institute (HCI). He received his M.D. from NYU, completed residency in Internal Medicine at Columbia-Presbyterian Medical Center in N.Y. and fellowship in Endocrinology, Diabetes & Metabolism at Massachusetts General Hospital and Harvard Medical School where he secured an NIH grant to study pituitary tumors. He was on faculty at George Washington University School of Medicine and The Ohio State College of Medicine with a 5-year NIH grant to study breast cancer. Then at Amgen he was Director of Medical Affairs for the launch of XGEVAÒ a medication for patients with cancer and bone metastases. Dr. Pinzone has taught numerous students, physicians, & scientists and published scientific papers. He wrote & hosted a PBS TV show Innovation in Biologic and Biosimilar Medications and appeared multiple times on the CBS TV series The Doctors. He was previously Assistant Professor of Clinical Medicine at David Geffen School of Medicine at UCLA.